InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
17,010.80
(
0.89%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
84.16
(
0.74%
)
Bitcoin
57,778.78
(
-0.79%
)
Post# of 251670
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (6) Keep Next 10 Report Keyboard Shortcuts
Replies (6) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119535
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 242413

Tuesday, 05/10/2022 7:15:07 AM

Tuesday, May 10, 2022 7:15:07 AM

Post# of 251670
PFE acquires BHVN for $148.50 cash—a 79% premium to yesterday’s close:

https://finance.yahoo.com/news/pfizer-acquire-biohaven-pharmaceuticals-104500807.html

The nominal deal value is $11.6B.

Both PFE and BHVN shareholders will receive 0.5 shares of a newly formed (as yet unnamed) company that will own BHVN’s non-migraine pipeline assets.

Note: PFE already owned the ex-US commercial rights to BHVN's Nurtec-ODT/Vydura by virtue of a deal announced in Nov 2021 (#msg-166695371). Vydura (the EU brand name) was approved for marketing in the EU two weeks ago (#msg-168679769).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (6) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (6) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up